TCWP’s Prestige Consumer Healthcare PBH Stock Holding History

TCWP’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-95	Closed	-$5K	–	1301
2022 Q1	$5K	Buy	+95	New	+$5.49K	﹤0.01%	1066

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

TCWP's PBH Position: Q2 2022 in Review

TCWP sold out of Prestige Consumer Healthcare (PBH) in Q2 2022, closing a stake of 95 shares — an estimated $5K sold.

TCWP first reported a position in PBH in Q1 2022 and held it in 1 quarter. The position peaked at $5K in Q1 2022. 285 funds tracked by Wall St. Rank hold PBH as of Q2 2022.

TCWP reported no remaining Prestige Consumer Healthcare position as of Q2 2022 after selling out during the quarter.
TCWP sold 95 Prestige Consumer Healthcare shares in Q2 2022, an estimated $5K.
TCWP first reported a position in Prestige Consumer Healthcare in Q1 2022 and held it in 1 quarter.
TCWP's Prestige Consumer Healthcare position peaked at $5K in Q1 2022.
285 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.